MoneyWorks4Me

Laurus Labs informs about closure of trading window

31 Mar 2023 Evaluate

 Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, Laurus Labs has informed that the trading window for dealing in the shares of the Company shall remain closed from April 01, 2023 till 48 hours after the declaration of audited financial results for the quarter and year ended March 31, 2023. The date of Board Meeting of the Company for consideration and approval of the audited financial results for the quarter and year ended March 31, 2023 will be intimated later.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..